clinical trial · NCT05366751
A Study to Evaluate the Long-term Safety and Tolerability of SAGE-324 in Participants With Essential Tremor
Essential TremorSAGE-324
brief summary
The primary purpose of this study is to evaluate the long-term safety and tolerability of SAGE-324 in participants with essential tremor (ET).
started
Jun 3, 2022
primary completion
Sep 10, 2024
completion
Sep 10, 2024
last updated
Aug 1, 2025
official title
An Open-label Study of the Long-term Safety and Tolerability of SAGE-324 in Participants With Essential Tremor
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol